| ADAPTIVE BIOTECHNOLOGIES |
| USA |
| Gesundheit |
| US00650F1093 / A2PLR5 |
| 1HM (Frankfurt) / ADPT (NASDAQ) |
| FRA:1HM, ETR:1HM, 1HM:GR, NASDAQ:ADPT |
| - |
| https://www.adaptivebiote.. |
|
Adaptive Biotechnologies Corporation is a commercial-stage biotechnology company that develops an immune medicine platform for diagnosing and treating various diseases. The company's core offering is its immunosequencing platform, which uses propriet..
>Volltext.. |
| 2435.06 Mio. EUR |
| 2433.11 Mio. EUR |
| 255.37 Mio. EUR |
| -24.89 Mio. EUR |
| -42.95 Mio. EUR |
| -0.28 EUR |
| 179.97 Mio. EUR |
| 67.07 Mio. EUR |
| -23.37 Mio. EUR |
| 2.51 |
| 45.95% |
| 67.2% |
| - |
| - |
| - |
| ADAPTIVE BIOTECHNOLOGIES, ADAPTIVE BIO, ADAPTIVE BIOTECH |
| 16.06.26 |